Allergic Rhinitis
Authors: Christine Laine
Journal: Annals of Internal Medicine (2007)

In the Clinic3 April 2007Allergic RhinitisChristine Laine, MD, MPH, David R. Goldman, MD, and Jennifer F. WilsonChristine Laine, MD, MPHSearch for more papers by this author, David R. Goldman, MDSearch for more papers by this author, and Jennifer F. WilsonSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-146-7-200704030-01004 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Allergic rhinitis (AR), an inflammatory disease of the upper airways, is one of the most common problems seen in outpatient practice. Although sometimes trivialized by patients and physicians, AR is a major source of morbidity. According to the National Health Interview Survey, 18.6 million adults and 6.7 children were diagnosed with hay fever in 2004 (www.cdc.gov/nchs/fastats/allergies.htm), and the National Ambulatory Medical Care Survey showed that there were 14 million physician office visits for AR that year (www.cdc.gov/nchs/fastats/allergies.htm). Exact prevalence figures for AR are difficult to determine. A recent study estimated that it affects 23% of the population of Western Europe ...References1. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis. Eur Respir J. 2004;24:758-64. [PMID: 15516669] Google Scholar2. Arbes SJ Jr, Gergen PJ, Elliott L, Zeldin DC. Prevalences of positive skin test responses to 10 common allergens in the US population: results from the Third National Health and Nutrition Examination Survey. J Allergy Clin Immunol. 2005;116:377-83. [PMID: 16083793] Google Scholar3. Fineman SM. The burden of allergic rhinitis: beyond dollars and cents. Ann Allergy Asthma Immunol. 2002;88(4 Suppl 1):2-7. [PMID: 11991546] Google Scholar4. Crystal-Peters J, Crown WH, Goetzel RZ, Schutt DC. The cost of productivity losses associated with allergic rhinitis. Am J Manag Care. 2000;6:373-8. [PMID: 10977437] Google Scholar5. Slavin RG, Reisman RE. Expert Guide to Allergy and Immunology. Philadelphia: American College of Physicians; 1999:23-40. Google Scholar6. Schoenwetter WF. Allergic rhinitis; epidemiology and natural history. Allergy Asthma Proc. 2000; 21:1-6. [PMID: 10748945] Google Scholar7. Quillen M, Feller DB. Diagnosing Rhinitis: Allergic vs. Nonallergic. Am Fam Physician. 73:1-6. [PMID: 16719251] Google Scholar8. van Cauwenberge P, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy. 2000;55:116-34. [PMID: 10726726] Google Scholar9. Palma-Carlos AG, Branco-Ferreira M, Palma-Carlos ML. Allergic rhinitis and asthma: more similarities than differences. Allerg Immunol (Paris). 2001; 33:237-41. [PMID: 11505808] Google Scholar10. Spector SL, Bernstein IL, Li JT, Berger WE, et al. Practice Parameters for the Diagnosis and Management of Sinusitis - J. Allergic Rhinitis. J Allergy Clin Immunol. 1998;102:S107-44. [PMID: 9847450] Google Scholar11. Gendo K, Larson EB. Evidence-based diagnostic strategies for evaluating suspected allergic rhinitis. Ann Intern Med. 2004;140:278-89. [PMID: 14970151] Google Scholar12. Pumhirun P, Jane-Trakoonroj S, Wasuwat P,. Comparison of in vitro assay for specific IgE and skin prick test with intradermal test in patients with allergic rhinitis. Asian Pac J Allergy Immunol. 2000.3:157-60. [PMID: 11270471] Google Scholar13. Sheikh A, Hurwitz B. House dust mite avoidance measures for perennial allergic rhinitis: a systematic review of efficacy. Br J Gen Pract. 2003;53:318-22. [PMID: 12879834] Google Scholar14. Fuhlbrigge AL, Adams RJ. The effect of treatment of allergic rhinitis on asthma morbidity, including emergency department visits. Curr Opin Allergy Clin Immunol. 2003;3:29-32. [PMID: 12582311] Google Scholar15. Skoner DP, Rachelefsky GS, Meltzer EO, et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics. 2000;105:E23. [PMID: 10654983] Google Scholar16. Schenkel EJ, Skoner DP, Bronsky EA, et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics. 2000;105:E22 [PMID: 10654982]. Google Scholar17. Weiler JM, Bloomfield JR, Woodworth GG, et al. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator. Ann Intern Med. 2000;132:354-63. [PMID: 10691585] Google Scholar18. Condemi J, Schulz R, Lim J. Triamcinolone acetonide aqueous nasal spray versus loratadine in seasonal allergic rhinitis: efficacy and quality of life. Ann Allergy Asthma Immunol. 2000;84:533-8 [PMID: 10831008] Google Scholar19. Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ.1998;317:1624-29 [PMID: 9848901]. Google Scholar20. Yáñez A, Rodrigo GJ. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol. 2002;89:479-84. [PMID: 12452206] Google Scholar21. Pullerits T, Praks L, Ristioja V, Lötvall J. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 2002;109:949-55. [PMID: 12063523] Google Scholar22. Di Lorenzo G, Pacor ML, Pellitteri ME, et al. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Clin Exp Allergy. 2004;34:259-67. [PMID: 14987306] Google Scholar23. Kakutani C, Ogino S, Ikeda H, Enomoto T. [Comparison of clinical efficacy and cost-quality of antihistamines in early treatment for Japanese cedar pollinosis]. Arerugi. 2006;55:554-65. [PMID: 16883093] Google Scholar24. Rodrigo GJ, Yañez A. The role of antileukotriene therapy in seasonal allergic rhinitis: a systematic review of randomized trials. Ann Allergy Asthma Immunol. 2006;96:779-86. [PMID: 16802764] Google Scholar25. Wilson AM, O'Byrne PM, Parameswaran K. Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis. Am J Med. 2004;116:338-44. [PMID: 14984820] Google Scholar26. Plaut M, Valentine MD. Clinical practice. Allergic rhinitis. N Engl J Med. 2005; 18:1934-44 [PMID: 16267324]. Google Scholar27. Colás C, Monzón S, Venturini M, Lezaun A. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule. J Allergy Clin Immunol. 2006;117:810-6. [PMID: 16630938] Google Scholar28. Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med. 1999;341:468-75. [PMID: 10441602] Google Scholar29. Immune Tolerance Network Group. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med. 2006;355:1445-55. [PMID: 17021320] Google Scholar30. Omalizumab Seasonal Allergic Rhinitis Trail Group. Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial. JAMA. 2001;286:2956-67. [PMID: 11743836] Google Scholar31. Huggins JL, Looney RJ. Allergen immunotherapy. Am Fam Physician. 2004;70:689-96. [PMID: 15338781] Google Scholar32. Möller C, Dreborg S, Ferdousi HA, Halken S, Host A, Jacobsen L, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol. 2002;109:251-6. [PMID: 11842293] Google Scholar33. Passalacqua G, Bousquet PJ, Carlsen KH, Kemp J, Lockey RF, Niggemann B, et al. ARIA update: I-Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol. 2006;117:1054-62. [PMID: 16675332] Google Scholar34. World Health Organization. Allergic rhinitis and its impact on asthma. In collaboration with the World Health Organization. Executive summary of the workshop report. 7-10 December 1999, Geneva, Switzerland. Allergy. 2002;57:841-55. [PMID: 12169183] Google Scholar Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoCorrection: In the Clinic: Allergic Rhinitis Metrics Cited byClinical practice guidelines for the treatment of allergic rhinitis in children with traditional Chinese medicineAre You Comfortable With Over-the-Counter Intranasal Steroids for Children? A Call to Action 3 April 2007Volume 146, Issue 7Page: ITC4-1KeywordsAllergensAllergic rhinitisAllergy and immunologyAllergy immunotherapyAsthmaDrug therapyDrugsQuality of lifeRhinitis ePublished: 3 April 2007 Issue Published: 3 April 2007 Copyright & PermissionsCopyright © 2007 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...